Elicio Therapeutics, Inc. (ELTX)
1.68
-0.07
(-4.00%)
USD |
NASDAQ |
Oct 30, 16:00
1.695
+0.02
(+0.89%)
After-Hours: 20:00
Elicio Therapeutics Price to Book Value : 4.636 for Oct. 30, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 30, 2026 | 4.636 |
| October 29, 2026 | 4.829 |
| October 28, 2026 | 5.105 |
| October 27, 2026 | 5.050 |
| October 26, 2026 | 4.691 |
| October 23, 2026 | 5.243 |
| October 22, 2026 | 5.353 |
| October 21, 2026 | 4.608 |
| October 20, 2026 | 4.332 |
| October 19, 2026 | 4.277 |
| October 16, 2026 | 4.305 |
| October 15, 2026 | 4.912 |
| October 14, 2026 | 4.939 |
| October 13, 2026 | 4.884 |
| October 12, 2026 | 5.188 |
| October 09, 2026 | 5.215 |
| October 08, 2026 | 4.995 |
| October 07, 2026 | 5.105 |
| October 06, 2026 | 5.188 |
| October 05, 2026 | 5.298 |
| October 02, 2026 | 5.298 |
| October 01, 2026 | 5.298 |
| September 30, 2026 | 5.022 |
| September 29, 2026 | 5.077 |
| September 28, 2026 | 5.105 |
| Date | Value |
|---|---|
| September 25, 2026 | 5.077 |
| September 24, 2026 | 5.188 |
| September 23, 2026 | 5.160 |
| September 22, 2026 | 5.160 |
| September 21, 2026 | 5.271 |
| September 18, 2026 | 5.215 |
| September 17, 2026 | 5.146 |
| September 16, 2026 | 4.884 |
| September 15, 2026 | 5.491 |
| September 14, 2026 | 5.519 |
| September 11, 2026 | 5.657 |
| September 10, 2026 | 5.822 |
| September 09, 2026 | 6.016 |
| September 08, 2026 | 6.485 |
| September 04, 2026 | 6.650 |
| September 03, 2026 | 6.899 |
| September 02, 2026 | 7.037 |
| September 01, 2026 | 7.064 |
| August 31, 2026 | 7.451 |
| August 28, 2026 | 7.837 |
| August 27, 2026 | 8.278 |
| August 26, 2026 | 8.223 |
| August 25, 2026 | 8.306 |
| August 24, 2026 | 8.223 |
| August 21, 2026 | 8.389 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Lineage Cell Therapeutics, Inc. | 4.152 |
| Armata Pharmaceuticals, Inc. | -- |
| Voyager Therapeutics, Inc. | 0.6827 |
| Black Diamond Therapeutics, Inc. | 1.064 |
| Invivyd, Inc. | 0.9469 |
Price to Book Value Related Metrics
| Price | 1.68 |
| Earnings Yield | -125.8% |
| Market Cap | 36.79M |